What is the first-line treatment of type 2 diabetes mellitus at the time of diagnosis?
This protocol covers the evidence-based approach to managing newly diagnosed type 2 diabetes mellitus — combining lifestyle intervention with pharmacotherapy initiated without delay.
Clinical Goal
Achievement and maintenance of an individualized glycemic target — an A1C below 7% — is the primary measure of treatment success. Many patients will require combination approaches to reach and sustain this goal.
Treatment Approach (partial summary)
Management begins immediately at diagnosis with healthy lifestyle behaviours and structured diabetes self-management education and support. First-line pharmacotherapy — metformin, an established oral agent — is started at the same time, unless contraindicated.
References
DOI: 10.2337/dc26-S009
- Metformin is a commonly used medication that historically has been the first-line treatment for type 2 diabetes.
- Metformin is available in an immediate-release form for twice-daily dosing or as an extended-release form that can be given once daily.
- Pharmacotherapy should be started at the time type 2 diabetes is diagnosed, without delay, unless there are contraindications.
- Many individuals will require dual-combination therapy or a more potent glucose-lowering agent to achieve and maintain their goal A1C level.